Definitive Healthcare Corp (DH) FinancialsDHDefinitive Healthcare Corp

Definitive Healthcare Corp (DH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Platform subscriptions, accounting for 95.7% of total sales, equivalent to $52.80M. Another important revenue stream is Professional services. Understanding this composition is critical for investors evaluating how DH navigates market cycles within the Software industry.

Evaluating the bottom line, Definitive Healthcare Corp maintains a gross margin of 57.97%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -7.99%, while the net margin is -13.50%. These profitability ratios, combined with a Return on Equity (ROE) of -75.04%, provide a clear picture of how effectively DH converts its operational activities into shareholder value.

In the context of the broader market, DH competes directly with industry leaders such as HCAT and ATGL. With a market capitalization of $137.60M, it holds a leading position in the sector. When comparing efficiency, DH's gross margin of 57.97% stands against HCAT's 34.64% and ATGL's 48.15%. Such benchmarking helps identify whether Definitive Healthcare Corp is trading at a premium or discount relative to its financial performance.

Definitive Healthcare reported total revenue of $55.9 million in Q1 2026, which was a 6% year-over-year decline. The gross margin has decreased to 57.97% in Q2 2026, down from 63.09% in Q3 2024, indicating declining profitability. The company has also reported significant net losses, with a Q1 net income of -$138.6 million.